Found: 30
Select item for more details and to access through your institution.
Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1553, doi. 10.1007/s12325-021-01963-9
- By:
- Publication type:
- Article
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1568, doi. 10.1007/s12325-021-01993-3
- By:
- Publication type:
- Article
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1697, doi. 10.1007/s12325-021-02012-1
- By:
- Publication type:
- Article
Correction to: Impact of Depression Onset and Treatment on the Trend of Annual Medical Costs in Japan: An Exploratory, Descriptive Analysis of Employer-Based Health Insurance Claims Data.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1810, doi. 10.1007/s12325-022-02068-7
- By:
- Publication type:
- Article
Therapeutic Advances in Viral Hepatitis A-E.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1743, doi. 10.1007/s12325-022-02067-8
- By:
- Publication type:
- Article
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1794, doi. 10.1007/s12325-022-02066-9
- By:
- Publication type:
- Article
Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1490, doi. 10.1007/s12325-022-02064-x
- By:
- Publication type:
- Article
Evaluation of Cognitive Deficits in Adults with Type 1 Diabetes Stratified by the Age of Diabetes Onset: A Cross-Sectional Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1711, doi. 10.1007/s12325-022-02063-y
- By:
- Publication type:
- Article
Comparison of Inconvenience Costs Between Influenza Antivirals for Japanese Pediatric Patients: A Conjoint Analysis of Parental Responses.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1724, doi. 10.1007/s12325-022-02062-z
- By:
- Publication type:
- Article
Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1754, doi. 10.1007/s12325-022-02060-1
- By:
- Publication type:
- Article
Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR Deficiencies.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1772, doi. 10.1007/s12325-022-02059-8
- By:
- Publication type:
- Article
Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1844, doi. 10.1007/s12325-022-02058-9
- By:
- Publication type:
- Article
Risk Factor Analysis of the Conservative Treatment in Chronic Subdural Hematomas: A Substudy of the ATOCH Trial.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1630, doi. 10.1007/s12325-022-02057-w
- By:
- Publication type:
- Article
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1457, doi. 10.1007/s12325-022-02056-x
- By:
- Publication type:
- Article
A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1678, doi. 10.1007/s12325-022-02054-z
- By:
- Publication type:
- Article
Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1582, doi. 10.1007/s12325-022-02053-0
- By:
- Publication type:
- Article
Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1596, doi. 10.1007/s12325-022-02051-2
- By:
- Publication type:
- Article
The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1474, doi. 10.1007/s12325-021-01948-8
- By:
- Publication type:
- Article
Podcast on the Management of Adverse Events Associated with Lorlatinib.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1447, doi. 10.1007/s12325-022-02050-3
- By:
- Publication type:
- Article
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1784, doi. 10.1007/s12325-022-02046-z
- By:
- Publication type:
- Article
Correction to: The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Real-World Evidence of Treatment with Teneligliptin/Canagliflozin Combination Tablets for Type 2 Diabetes Mellitus: A Post-Marketing Surveillance in Japan.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1642, doi. 10.1007/s12325-021-02038-5
- By:
- Publication type:
- Article
Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid Leukemia.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1857, doi. 10.1007/s12325-021-02031-y
- By:
- Publication type:
- Article
Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1659, doi. 10.1007/s12325-021-02023-y
- By:
- Publication type:
- Article
A Feasibility Study: Testing Whether a Sleep Application Providing Objective Sleep Data to Physicians Improves Patient–Physician Communication Regarding Sleep Experiences, Habits, and Behaviors.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1612, doi. 10.1007/s12325-021-02013-0
- By:
- Publication type:
- Article